About Jazz Pharmaceuticals Plc

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Dublin, Ireland.

At the moment the company generates 2056M USD in revenues.

On its last earning announcement, the company reported a profit of 10.42$ per share.

The book value per share is 47.51$

Jazz Pharmaceuticals Plc website


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
2056M 94.20% 766M 37.29% 609M 10.42 - - 58M 47.51 907M -180M 726M